Integrative role of cPLA2 with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis

被引:63
作者
Kiaei, M [1 ]
Kipiani, K [1 ]
Petri, S [1 ]
Choi, DK [1 ]
Chen, JY [1 ]
Calingasan, NY [1 ]
Beal, MF [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA
关键词
arachidonic acid; cytosolic phospholipase A2; inflammation; microglial activation; sulindac; superoxide dismutase;
D O I
10.1111/j.1471-4159.2005.03024.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclooxygenase-2 (COX-2) is a key molecule in the inflammatory pathway in amyotrophic lateral sclerosis (ALS). Cytosolic phospholipase A (cPLA2) is an important enzyme providing substrate for cyclooxygenases. We therefore examined cPLA2 expression in human ALS and mutant Cu/Zn superoxide dismutase (SOD1) transgenic mice and its relation to COX-2. Immunohistochemistry and real-time RT-PCR revealed elevated cPLA2 protein and its mRNA levels in the lumbar spinal cord of mutant SOD1 mice. COX-2 immunoreactivity was increased in lumbar spinal cord sections from both familial ALS (FALS) and sporadic ALS (SALS) as compared to controls, and cPLA2 immunoreactivity was increased in a patient with FALS. Oral administration of the non-selective cyclooxygenase (COX) inhibitor, sulindac, extended the survival (by 10%) of G93A SOD1 mice as compared to littermate controls. Sulindac, as well as the selective COX-2 inhibitors, rofecoxib and celecoxib reduced cPLA2 immunoreactivity in the lumbar spinal cord of G93A transgenic mice. Sulindac treatment preserved motor neurons, and reduced microglial activation and astrocytosis, in the spinal cord of G93A SOD1 transgenic mice. These results suggest that cPLA2 plays an important role in supplying arachidonic acid to the COX-2 driven inflammatory pathway in ALS associated with SOD1 mutations.
引用
收藏
页码:403 / 411
页数:9
相关论文
共 33 条
[1]  
Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.3.CO
[2]  
2-O
[3]  
Almer G, 2002, NEUROLOGY, V58, pA463
[4]   Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A(2) [J].
Bonventre, JV ;
Huang, ZH ;
Taheri, MR ;
OLeary, E ;
Li, E ;
Moskowitz, MA ;
Sapirstein, A .
NATURE, 1997, 390 (6660) :622-625
[5]   The expression of brain cyclooxygenase-2 is down-regulated in the cytosolic phospholipase A2 knockout mouse [J].
Bosetti, F ;
Weerasinghe, GR .
JOURNAL OF NEUROCHEMISTRY, 2003, 87 (06) :1471-1477
[6]   ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions [J].
Bruijn, LI ;
Becher, MW ;
Lee, MK ;
Anderson, KL ;
Jenkins, NA ;
Copeland, NG ;
Sisodia, SS ;
Rothstein, JD ;
Borchelt, DR ;
Price, DL ;
Cleveland, DW .
NEURON, 1997, 18 (02) :327-338
[7]   INDUCTION BY LIPOPOLYSACCHARIDE OF CYCLOOXYGENASE-2 MESSENGER-RNA IN FAT BRAIN - ITS POSSIBLE ROLE IN THE FEBRILE RESPONSE [J].
CAO, CY ;
MATSUMURA, K ;
YAMAGATA, K ;
WATANABE, Y .
BRAIN RESEARCH, 1995, 697 (1-2) :187-196
[8]   Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS [J].
Drachman, DB ;
Frank, K ;
Dykes-Hoberg, M ;
Teismann, P ;
Almer, G ;
Przedborski, S ;
Rothstein, JD .
ANNALS OF NEUROLOGY, 2002, 52 (06) :771-778
[9]   Reduction of Sulindac to its active metabolite, sulindac sulfide: assay and role of the methionine sulfoxide reductase system [J].
Etienne, F ;
Resnick, L ;
Sagher, D ;
Brot, N ;
Weissbach, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 312 (04) :1005-1010
[10]   MOTOR-NEURON DEGENERATION IN MICE THAT EXPRESS A HUMAN CU,ZN SUPEROXIDE-DISMUTASE MUTATION [J].
GURNEY, ME ;
PU, HF ;
CHIU, AY ;
DALCANTO, MC ;
POLCHOW, CY ;
ALEXANDER, DD ;
CALIENDO, J ;
HENTATI, A ;
KWON, YW ;
DENG, HX ;
CHEN, WJ ;
ZHAI, P ;
SUFIT, RL ;
SIDDIQUE, T .
SCIENCE, 1994, 264 (5166) :1772-1775